A Randomized, Open-label, Controlled, Phase 2 Study of Pevonedistat, Venetoclax, and Azacitidine Versus Venetoclax Plus Azacitidine in Adults With Newly Diagnosed Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy

  • Hildebrandt, Gerhard (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date12/31/20 → 11/7/22